Navigation Links
AACR recognizes the outstanding achievements of Pier Paolo Pandolfi
Date:3/25/2011

ORLANDO, Fla. Pier Paolo Pandolfi, M.D., Ph.D., is the recipient of the 2011 Pezcoller Foundation-AACR International Award for Cancer Research for his outstanding work in the field of cancer genetics and mouse models for cancer. This work has contributed to new therapies for treating cancers.

"Dr. Pandolfi's research has had a profound impact on our understanding of the molecular underpinnings of acute promyelocytic leukemia (APL)," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "His laboratory's mouse models for various subtypes of APL have shown efficacy when utilizing different drug combinations. Clearly, this innovative research is leading to progress in the treatment of other types of cancer."

Pandolfi is the George C. Reisman Professor of Medicine and a professor of pathology at Harvard Medical School; director of research at the Beth Israel Deaconess Cancer Center; and director of the cancer genetics program and chief of the division of genetics in the department of medicine at the Beth Israel Deaconess Medical Center. His studies have had an impact on the cancer research arena by broadening the understanding of the molecular basis of cancer.

The research carried out in Pandolfi's laboratory has been important in understanding the molecular mechanisms and genetics underlying the pathogenesis of leukemias, lymphomas and solid tumors, as well as in modeling these cancers in mice.

Among his many accomplishments, Pandolfi and colleagues have characterized the function of oncoproteins and genes involved in the chromosomal translocations of APL, as well as of major tumor suppressors such as PTEN and p53, and novel proto-oncogenes, such as POKEMON. These accomplishments have led to the development of novel and effective therapeutic strategies, and, as a result, APL is now considered a curable disease.

Additional novel therapeutic concepts have emerged from Pandolfi's research, which are currently being tested in clinical trials. More recently, Pandolfi and colleagues have presented a new theory describing how mRNA, both coding and non-coding, exerts biological functions with profound implications for human genetics, cell biology and cancer biology.

Pandolfi received his medical degree in 1989 and his doctorate in 1996 from the University of Perugia in Italy, after he studied philosophy at the University of Rome. He received post-graduate training at the National Institute for Medical Research and the University of London in the United Kingdom.

In 1994, Pandolfi became an assistant member of the molecular biology program and the department of human genetics at Memorial Sloan-Kettering Cancer Center. He grew through the ranks to become a member in the cancer biology and genetics program at the Sloan-Kettering Institute; professor of molecular biology and human genetics, and professor of molecular biology in pathology and laboratory medicine at the Weill Graduate School of Medical Sciences at Cornell University; and head of the molecular and developmental biology laboratories, and the incumbent of the Albert C. Foster Endowed Chair for Cancer Research at Memorial Sloan-Kettering Cancer Center.

Among his lauded career experiences, Pandolfi has also received numerous awards including: the LLSA Scholar Award (1997); the Irma T. Hirschl Trust Award (1999); the Alexandra J. Kefalides Prize for Leukemia Research (1999); the Hamdan Award for Medical Research Excellence (2000); the Lombroso Prize for Cancer Research of the Weizmann Institute of Science (2001); the Leukemia and Lymphoma Society's Stohlman Scholar Award (2001); the William and Linda Steere Foundation Award (2004); and, the prize for Scientific Excellence in Medicine from the American-Italian Cancer Foundation (2005).

He also has been awarded the National Institutes of Health MERIT Award, the Fondazione Cortese International Award, the Prostate Cancer Foundation Creativity Award and the Ischia International Award. In 2006, Pandolfi was elected as a member of the American Society for Clinical Investigation and the American Association of Physicians, and the following year he became a member of the European Molecular Biology Organization.

The Pezcoller Foundation-AACR International Award, now in its 14th year, recognizes an individual scientist of international renown who has made a major scientific discovery in basic or translational cancer research.

Pandolfi will give an award lecture during the AACR 102nd Annual Meeting 2011, on Monday April 4 at 5 p.m. ET in the Orange County Convention Center, Orlando, Fla.


'/>"/>

Contact: Michele Sharp
Michele.Sharp@aacr.org
267-646-0622
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. ASGE recognizes 35 endoscopy units for quality and safety as part of its Endoscopy Unit Recognition Program
2. EMBO recognizes 63 researchers for advances in life sciences
3. ASGE recognizes 48 endoscopy units for quality as part of its Endoscopy Unit Recognition Program
4. The John Theurer Cancer Center recognizes medical physics team for safety track record
5. Child Life Council Recognizes Leaders in Child Life for Distinguished Service, Clinical Excellence and Philanthropic Support at 28th Annual Conference
6. Vitals.com Recognizes Two RMACT Fertility Doctors as 'Leading On-Time Doctors'
7. Verdict Search recognizes Applied Forensics in Top 25 New York Verdicts of 2009
8. American Brain Tumor Association Recognizes Philadelphia Family Foundation With Annual Award
9. Georgia Kidney Community Recognizes World Kidney Day; Echoes Need for Legislation to Improve Access to Dialysis and Transplant Care
10. Department of Public Welfare Recognizes Contributions of Pennsylvanians with Developmental Disabilities
11. DAV Recognizes President for Supporting Veterans Health Care Budget Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... ... Discover the Rocky Mountain region’s longest running and impressive garden and home show ... to see the most incredible gardens and home improvement experts that attend this amazing ... Center - 700 14th St. Denver CO, is an exciting event that Performance Mobility ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... Inc., will be speaking on how healthcare companies can use newly released government ... the health of a population and intervene and capture the value they create ...
(Date:2/7/2016)... Metamora, Michigan (PRWEB) , ... February 07, 2016 ... ... pelvic organ prolapse with the latest techniques and the most minimally invasive approaches. ... pelvic organ prolapse, particularly after menopause. Other risk factors include surgery to the ...
(Date:2/6/2016)... ... February 06, 2016 , ... FOR INFORMATION: ... AORN SURGICAL CONFERENCE & EXPO , WHAT:     , This conference is the ... perioperative nurses in attendance to study the latest evidence-based recommendations and resources ...
(Date:2/6/2016)... Pekin, IL (PRWEB) , ... February 06, 2016 ... ... the recovery phases of eating disorder treatment helps to reduce the frequency and ... “Tasks of the Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... DIEGO , Feb. 8, 2016 /PRNewswire/--  Cell ... announced that advanced tissue-engineering services are now available ... a groundbreaking new three-dimensional (3D) bioprinting approach called ... 3D Bio Printer , a state-of-the-art robotic system ... has created a powerful pay-for-service bio-printing model that ...
(Date:2/8/2016)... , Feb. 8, 2016 ... addition of the "Label-Free Detection Market ... to 2020" report to their offering. ... the addition of the "Label-Free Detection ... Forecasts to 2020" report to their ...
(Date:2/8/2016)... Pharma Inc. President and Chief Executive Officer Yoshihiko Hatanaka ... as president, Americas Operations, for Astellas US LLC, with responsibility ... America , effective April 1, 2016.  Robinson previously served ... the United States -- a role ... who is retiring in June 2016.  --> ...
Breaking Medicine Technology: